GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Piotroski F-Score

SSMXY (Sysmex) Piotroski F-Score : 8 (As of Apr. 01, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex Piotroski F-Score?

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sysmex has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Sysmex's Piotroski F-Score or its related term are showing as below:

SSMXY' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 9
Current: 8

During the past 13 years, the highest Piotroski F-Score of Sysmex was 9. The lowest was 3. And the median was 6.


Sysmex Piotroski F-Score Historical Data

The historical data trend for Sysmex's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Piotroski F-Score Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 5.00 9.00 6.00 6.00

Sysmex Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 7.00 8.00 8.00

Competitive Comparison of Sysmex's Piotroski F-Score

For the Medical Devices subindustry, Sysmex's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sysmex's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 101.289 + 69.878 + 104.726 + 108.007 = $384 Mil.
Cash Flow from Operations was 167.115 + 113.81 + 225.002 + 57.153 = $563 Mil.
Revenue was 900.99 + 709.147 + 913.112 + 808.683 = $3,332 Mil.
Gross Profit was 472.058 + 380.331 + 498.454 + 438.932 = $1,790 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(3939.395 + 4131.129 + 3967.116 + 4323.496 + 4241.4) / 5 = $4120.5072 Mil.
Total Assets at the begining of this year (Dec23) was $3,939 Mil.
Long-Term Debt & Capital Lease Obligation was $330 Mil.
Total Current Assets was $2,325 Mil.
Total Current Liabilities was $744 Mil.
Net Income was 79.296 + 60.98 + 91.751 + 85.268 = $317 Mil.

Revenue was 836.117 + 674.535 + 793.716 + 790.56 = $3,095 Mil.
Gross Profit was 457.983 + 356.598 + 409.929 + 421.992 = $1,647 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(3716.679 + 3973.193 + 3788.251 + 3773.1 + 3939.395) / 5 = $3838.1236 Mil.
Total Assets at the begining of last year (Dec22) was $3,717 Mil.
Long-Term Debt & Capital Lease Obligation was $293 Mil.
Total Current Assets was $2,118 Mil.
Total Current Liabilities was $684 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sysmex's current Net Income (TTM) was 384. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sysmex's current Cash Flow from Operations (TTM) was 563. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=383.9/3939.395
=0.09745151

ROA (Last Year)=Net Income/Total Assets (Dec22)
=317.295/3716.679
=0.08537057

Sysmex's return on assets of this year was 0.09745151. Sysmex's return on assets of last year was 0.08537057. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sysmex's current Net Income (TTM) was 384. Sysmex's current Cash Flow from Operations (TTM) was 563. ==> 563 > 384 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=330.164/4120.5072
=0.08012703

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=293.038/3838.1236
=0.07634929

Sysmex's gearing of this year was 0.08012703. Sysmex's gearing of last year was 0.07634929. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=2325.278/743.93
=3.12566774

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=2118.119/684.039
=3.09648865

Sysmex's current ratio of this year was 3.12566774. Sysmex's current ratio of last year was 3.09648865. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sysmex's number of shares in issue this year was 623.766. Sysmex's number of shares in issue last year was 625.851. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1789.775/3331.932
=0.53715832

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1646.502/3094.928
=0.5320001

Sysmex's gross margin of this year was 0.53715832. Sysmex's gross margin of last year was 0.5320001. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=3331.932/3939.395
=0.8457979

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=3094.928/3716.679
=0.83271329

Sysmex's asset turnover of this year was 0.8457979. Sysmex's asset turnover of last year was 0.83271329. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sysmex has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Sysmex  (OTCPK:SSMXY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sysmex Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sysmex's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

From GuruFocus

Q3 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020

Q1 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2020 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research 02-15-2024